Sunrest Lifescience IPO product range encompasses a variety of pharmaceutical forms, including capsules, tablets, syrups, ointments, gels, mouthwashes, solutions, suspensions, dry powders, and toothpaste. Their diverse product portfolio covers a wide spectrum of medications, including antibacterial, antidiarrheal, antifungal, antidiabetic, dental care, antiprotozoal, antihistamine, antihypertensive, cosmetic, antiparasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory drugs. The company holds 18 registered trademarks for 32 products, indicating their commitment to quality and brand recognition.
Sunrest Lifescience distributes its products to stockists and super stockists, making them readily available at chemist shops, dispensaries, hospitals, and other healthcare facilities.
Sunrest Lifescience IPO Timeline
Sunrest Lifescience IPO opens on November 7, 2023, and closes on November 9, 2023.
|IPO Open Date||Tuesday, November 7, 2023|
|IPO Close Date||Thursday, November 9, 2023|
|Basis of Allotment||Wednesday, November 15, 2023|
|Initiation of Refunds||Thursday, November 16, 2023|
|Credit of Shares to Demat||Friday, November 17, 2023|
|Listing Date||Monday, November 20, 2023|
|Cut-off time for UPI mandate confirmation||5 PM on November 9, 2023|
Sunrest Lifescience IPO Lot Size
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
About the Issue
Sunrest Lifescience IPO is set to raise Rs 10.85 crores through a fixed price issue. This IPO comprises entirely fresh shares, totaling 12.91 lakh shares.
The subscription period for Sunrest Lifescience IPO will be open from November 7, 2023, to November 9, 2023. The allotment of shares is expected to be finalized by Wednesday, November 15, 2023. Sunrest Lifescience IPO is set to list on the NSE SME platform, with a tentative listing date of Monday, November 20, 2023.
The price per share in the Sunrest Lifescience IPO is set at ₹84. Retail investors can apply for a minimum of 1600 shares, amounting to an investment of ₹134,400. High Net Worth Individuals (HNI) can apply for a minimum of 3,200 shares, which corresponds to an investment of ₹268,800.
Sunrest Lifescience Limited Financials
Sunrest Lifescience Limited’s revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
|Period Ended||30 Jun 2023||31 Mar 2023||31 Mar 2022||31 Mar 2021|
|Profit After Tax||75.08||204.31||77.71||16.55|
|Reserves and Surplus||86.60||11.52||106.20||28.49|
Objects of the Issue:
- Meeting Working Capital Requirements
- General Corporate Purpose
- Meeting Public Issue Expenses
Sunrest Lifescience IPO Registrar
Skyline Financial Services Private Ltd
Sunrest Lifescience Limited
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar, Bus Stand Vastral Road,
Phone: +91-079 – 29918245
Sunrest Lifescience IPO FAQs
What is Sunrest Lifescience IPO?
Sunrest Lifescience IPO is an NSE SME IPO. They are going to raise ₹10.85 Crores via IPO. The issue is priced at ₹84 per equity share. The IPO is to be listed on NSE.
When Sunrest Lifescience IPO will open?
The IPO is to open on November 7, 2023 for QIB, NII, and Retail Investors.
What is Sunrest Lifescience IPO Investors Portion?
The investors’ portion for NII is 50%, and Retail is 50%.
How to Apply the Sunrest Lifescience IPO through Zerodha?
Steps to apply in Sunrest Lifescience IPO through Zerodha
- Visit the Zerodha website and login to Console.
- Go to Portfolio and click the IPOs link.
- Go to the ‘Sunrest Lifescience IPO’ row and click the ‘Bid’ button.
- Enter your UPI ID, Quantity, and Price.
- ‘Submit’ IPO application form.
- Visit the UPI App (net banking or BHIM) to approve the mandate.